Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy
JACC: Clinical Electrophysiology · 2024
DOI: 10.1016/j.jacep.2024.02.031 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2024. Verfasst von Francisco J Bermudez-Jimenez und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Virgen de las Nieves University Hospital, Granada, Spain; Instituto de Investigación Biosanitaria. ibs.GRANADA, Granada, Sp…. Hauptthemen laut MEDLINE: Phenotype, Death, Sudden, Cardiac, Desmin, Arrhythmogenic Right Ventricular Dysplasia. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
BACKGROUND: Desmin (DES) pathogenic variants cause a small proportion of arrhythmogenic cardiomyopathy (ACM). Outcomes data on DES-related ACM are scarce. OBJECTIVES: This study sought to provide information on the clinical phenotype and outcomes of patients with ACM caused by pathogenic variants of the DES gene in a multicenter cohort. METHODS: We collected phenotypic and outcomes data from 16 families with DES-related ACM from 10 European centers. We assessed in vitro DES aggregates. Major cardiac events were compared to historical controls with lamin A/C truncating variant (LMNA-tv) and filament C truncating variant (FLNC-tv) ACM. RESULTS: Of 82 patients (54% males, median age: 36 years), 11 experienced sudden cardiac death (SCD) (n = 7) or heart failure death (HFd)/heart transplantation (HTx) (n = 4) before clinical evaluation. Among 68 survivors, 59 (86%) presented signs of cardiomyopathy, with left ventricular (LV) dominant (50%) or biventricular (34%) disease. Mean LV ejection fraction was 51% ± 13%; 36 of 53 had late gadolinium enhancement (ring-like pattern in 49%). During a median of 6.73 years (Q1-Q3: 3.55-9.52 years), the composite endpoint (sustained ventricular tachycardia, aborted SCD, implantable cardioverter-defibrillator therapy, SCD, HFd, and HTx) was achieved in 15 additional patients with HFd/HTx (n = 5) and SCD/aborted SCD/implantable cardioverter-defibrillator therapy/sustained ventricular tachycardia (n = 10). Male sex (P = 0.004), nonsustained ventricular tachycardia (P = 0.017) and LV ejection fraction ≤50% (P = 0.012) were associated with the composite endpoint. Males with DES variants had similar outcomes to historical FLNC-tv and LMNA-tv controls. However, females showed better outcomes than those with LMNA-tv. In vitro experiments showed the characteristic finding of DES aggregates in 7 of 12 variants. CONCLUSIONS: DES ACM is associated with poor outcomes which can be predicted with potentially successful treatments, underscoring the importance of familial evaluation and genetic studies to identify at risk individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Virgen de las Nieves University Hospital, Granada, Spain; Instituto de Investigación Biosanitaria. ibs.GRANADA, Granada, Spain.
- Inherited Cardiovascular Diseases Unit, St Bartholomew's Hospital, London, United Kingdom; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, United Kingdom.
- Instituto de Investigación Biomédica de A Coruña (INIBIC, CIBERCV), A Coruña, Spain; Health in Code SL, Cardiología, A Coruña, Spain.
- Department of Cardiology, Puerta del Mar University Hospital, Cádiz, Spain; Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cádiz, Spain.
- Departments of Biology and Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
- Inherited Cardiac Diseases Unit, Cardiology Department at Hospital Universitario y Politécnico La Fe and Research Group on Inherited Heart Diseases, Sudden Death and Mechanisms of Disease (CaFaMuSMe), Barcelona, Spain;…
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Bermudez-Jimenez, F. J., Protonotarios, A., García-Hernández, S., Pérez Asensio, A., Rampazzo, A., Zorio, E., Brodehl, A., Arias, M. A., Macías-Ruiz, R., Fernández-Armenta, J., Remior Perez, P., Muñoz-Esparza, C., Pilichou, K., Bauce, B., Merino, J. L., Moliner-Abós, C., Ochoa, J. P., Barriales-Villa, R., Garcia-Pavia, P., …, & Jimenez-Jaimez, J. (2024). Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2024.02.031
Vancouver
Bermudez-Jimenez FJ, Protonotarios A, García-Hernández S, Pérez Asensio A, Rampazzo A, Zorio E, et al. Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy. JACC: Clinical Electrophysiology. 2024. doi:10.1016/j.jacep.2024.02.031
BibTeX
@article{BermudezJimenez2024,
author = {Bermudez-Jimenez, Francisco J and Protonotarios, Alexandros and García-Hernández, Soledad and Pérez Asensio, Ana and Rampazzo, Alessandra and Zorio, Esther and Brodehl, Andreas and Arias, Miguel A and Macías-Ruiz, Rosa and Fernández-Armenta, Juan and Remior Perez, Paloma and Muñoz-Esparza, Carmen and Pilichou, Kalliopi and Bauce, Barbara and Merino, Jose L and Moliner-Abós, Carlos and Ochoa, Juan P and Barriales-Villa, Roberto and Garcia-Pavia, Pablo and Lopes, Luis R and Syrris, Petros and Corrado, Domenico and Elliott, Perry M and McKenna, William J and Jimenez-Jaimez, Juan},
title = {Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy},
journal = {JACC: Clinical Electrophysiology},
year = {2024},
doi = {10.1016/j.jacep.2024.02.031}
}
EUVIMED